Literature DB >> 6735470

Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A.

S Kotani, H Takada, M Tsujimoto, T Ogawa, K Harada, Y Mori, A Kawasaki, A Tanaka, S Nagao, S Tanaka.   

Abstract

Synthetic lipid A analogs which have two amide-bound and two ester-bound (R)-3-hydroxytetradecanoyl groups at the C-2 and -2' and C-3 and -3' positions of beta(1-6)glucosamine disaccharide mono- or diphosphates showed high activities in most in vitro assays, and the lethality of a diphosphate derivative to galactosamine-treated mice was almost comparable to that of natural lipid A. The pyrogenicity and Shwartzman induction activity of the synthetic analogs, however, were much less than those of natural lipid A.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6735470      PMCID: PMC263318          DOI: 10.1128/iai.45.1.293-296.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  New limulus amoebocyte lysate test for endotoxaemia.

Authors:  T Obayashi; T Kawai; H Tamura; C Nakahara
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

2.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1975-06

Review 3.  Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.

Authors:  O Westphal; K Jann; K Himmelspach
Journal:  Prog Allergy       Date:  1983

4.  Endotoxins of Gram-negative bacteria.

Authors:  O Lüderitz; C Galanos; E T Rietschel
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

5.  Isolation, purification and properties of an intermediate in 3-deoxy-D-manno-octulosonic acid--lipid A biosynthesis.

Authors:  V Lehmann
Journal:  Eur J Biochem       Date:  1977-05-02

6.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Characterization of lipopolysaccharide from a heptoseless mutant of Escherichia coli by carbon 13 nuclear magnetic resonance.

Authors:  S M Strain; S W Fesik; I M Armitage
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

8.  Fatty acyl derivatives of glucosamine 1-phosphate in Escherichia coli and their relation to lipid A. Complete structure of A diacyl GlcN-1-P found in a phosphatidylglycerol-deficient mutant.

Authors:  K Takayama; N Qureshi; P Mascagni; M A Nashed; L Anderson; C R Raetz
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

9.  Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.

Authors:  A Tanaka; S Nagao; K Imai; R Mori
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

10.  Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; Y Mori; M Sakuta; A Kawasaki; M Inage; S Kusumoto; T Shiba; N Kasai
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more
  24 in total

1.  Local skin response in mice induced by a single intradermal injection of bacterial lipopolysaccharide and lipid A.

Authors:  Y Ishikawa; T Kirikae; M Hirata; M Yoshida; Y Haishima; S Kondo; K Hisatsune
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Somnogenic activities of synthetic lipid A.

Authors:  A B Cady; S Kotani; T Shiba; S Kusumoto; J M Krueger
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

Review 3.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

4.  Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A.

Authors:  R A Proctor; J A Textor
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

5.  Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; I Takahashi; T Ikeda; K Otsuka; H Shimauchi; N Kasai; J Mashimo
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

8.  Immunobiological activities of synthetic lipid A analogs with low endotoxicity.

Authors:  S Kotani; H Takada; I Takahashi; T Ogawa; M Tsujimoto; H Shimauchi; T Ikeda; H Okamura; T Tamura; K Harada
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

9.  Endotoxic induction of prostaglandin release from macrophages by nontoxic lipid A analogs synthesized chemically.

Authors:  K Tanamoto; U Shade; E T Rietschel; S Kusumuto; T Shiba
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

10.  Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.

Authors:  D T Golenbock; J A Will; C R Raetz; R A Proctor
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.